RxDoctor Payments Data

Thomas Gleason, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Asheville, NCNPI 1134164239

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 65.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $9,817 and has fallen 81.5% since, to $1,812 in 2025.

$12,599in general payments, 2019–2025

Across 60 payments — averaging $209.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Artivion, Inc.$2K
  • Medtronic$1K
  • Baxter Healthcare$200
  • Bolton Medical Inc$165
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$96
  • plus $122 from 4 others
$461,214in research payments, 2019–2025

Across 72 payments — averaging $6405.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$300K
  • Boston Scientific$71K
  • Edwards Lifesciences$63K
  • Abbott$18K
  • Cook Research Incorporated$10K

What the payments were for

  • Consulting fees$6,45951%
  • Travel & lodging$4,10633%
  • Food & beverage$2,03516%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,599 in reported general payments places this provider in the 65th percentile of 132 thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina.

See all thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina

Medicare billing

Part B allowed, 2024
$205,664
Medicare patients
196
Services billed
510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →